Back
Open Access

Multimodal screening of transthyretin amyloid cardiomyopathy through artificial intelligence applied to electrocardiographic images and point-of-care ultrasound: a multi-center study

Session: ePosters in myocardial disease (2)
Topic: Clinical
Speaker: Doctor E. Oikonomou (New Haven, US)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Evangelos K Oikonomou

Yale School of Medicine, New Haven (United States of America)
1 presentation
1 follower

8 more presentations in this session

Effects of tafamidis on pacemaker therapy

Speaker: Doctor M. Figueiredo (Barreiro, PT)

Access
Abstract
Like
Thumbnail

Clinical characteristics, mortality outcomes and survival predictors of transthyretin cardiac amyloidosis in an Asian registry

Speaker: Doctor V. Putri (Singapore, SG)

Access
Abstract
Like
Thumbnail

A descriptive journey through the heart of transthyretin cardiac amyloidosis

Speaker: Doctor M. Rodrigues Simoes (Coimbra, PT)

Access
Abstract
Like
Thumbnail

Diagnostic value of the right ventricular wall thickness and free wall strain ratio in distinguishing hypertrophic cardiomyopathy and wild-type transthyretin cardiac amyloidosis

Speaker: Doctor E. Mata (Creixomil, PT)

Access
Abstract
Like
Thumbnail

Red-flags for cardiac amyloidosis in real life of an internal medicine department

Speaker: Doctor I. Fiteni Mera (Zaragoza, ES)

Access
Abstract
Like
Thumbnail

Access the full session

ePosters in myocardial disease (2)

Speakers: Doctor E. Oikonomou, Doctor M. Figueiredo, Doctor V. Putri, Doctor M. Rodrigues Simoes, Doctor E. Mata...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources